Rang	Name	Position
1	Mr. Todd Foley M.B.A.	Co-Founder & Chairman
2	Dr. Matthew Roden Ph.D.	President, CEO & Director
3	Dr. Paul L. Feldman Ph.D.	Chief Scientific Officer
4	Dr. Akos Czibere M.D., Ph.D.	Chief Medical Officer
5	Dr. Patrick A. Baeuerle Ph.D.	Co-Founder & Member of Scientific Advisory Board
6	Mr. Kyle D. Kuvalanka	Chief Financial Officer
7	Dr. Shulamit Ron-Bigger Ph.D.	Chief Operating Officer
8	Dr. Tyler Benedum Ph.D.	Chief Technical Officer
9	Mr. Carlos Rodriguez	Executive Director of Corporate Development
10	Dr. Dasa Lipovsek Ph.D.	VP & Head of Lead Discovery

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	MPM Oncology Impact Management LP	8,69%	0,11 Mrd. USD
2	EcoR1 Capital, LLC	8,67%	0,11 Mrd. USD
3	Blue Owl Capital Holdings LP	5,52%	0,07 Mrd. USD
4	T. Rowe Price Investment Management,Inc.	3,82%	0,05 Mrd. USD
5	BlackRock Inc	3,80%	0,05 Mrd. USD
6	Wellington Management Company LLP	3,54%	0,05 Mrd. USD
7	RTW INVESTMENTS, LLC	2,86%	0,04 Mrd. USD
8	T. Rowe Price Associates, Inc.	2,81%	0,04 Mrd. USD
9	RA Capital Management, LLC	2,70%	0,04 Mrd. USD
10	HHG PLC	2,61%	0,03 Mrd. USD
11	Baker Bros Advisors LP	1,79%	0,02 Mrd. USD
12	Octagon Capital Advisors LP	1,73%	0,02 Mrd. USD
13	Merck & Co Inc	1,71%	0,02 Mrd. USD
14	Vanguard Capital Management, LLC	1,50%	0,02 Mrd. USD
15	TCG Crossover Management, LLC	1,25%	0,02 Mrd. USD
16	Eventide Asset Management, LLC	0,91%	0,01 Mrd. USD
17	Geode Capital Management, LLC	0,88%	0,01 Mrd. USD
18	Avidity Partners Management LP	0,87%	0,01 Mrd. USD
19	State Street Corp	0,77%	0,01 Mrd. USD
20	FMR Inc	0,69%	0,01 Mrd. USD